SCHEMBL3845915

SCHEMBL3845915

C=COC(=O)c1ccccc1[C@@H]1CC2C3CCc4ccccc4C3CC[C@]2(C)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.39
CYP3A4 P08684 3/20 0.38
ESR1 P03372 6/20 0.38
LMNA P02545 4/20 0.38
SHBG P04278 3/20 0.38
KMT2A Q03164 2/20 0.38
SLC6A4 P31645 2/20 0.38
HTR2B P41595 2/20 0.38
ADORA3 P0DMS8 2/20 0.38
ATM Q13315 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NR3C1 P04150 1/20 0.38
FYN P06241 1/20 0.38
ADRA2C P18825 1/20 0.38
SLC6A2 P23975 1/20 0.38
HTT P42858 1/20 0.38
STS P08842 2/20 0.35
MEN1 O00255 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846561 0.86 STS (0.39) AKR1C3CYP3A4ESR1LMNASHBG
SCHEMBL5682532 0.74 SHBG (0.48) AKR1C3CYP3A4ESR1LMNASHBG
SCHEMBL8518161 0.74 SHBG (0.48) AKR1C3CYP3A4ESR1LMNASHBG
SCHEMBL5682603 0.74 SHBG (0.48) AKR1C3CYP3A4ESR1LMNASHBG
SCHEMBL9255609 0.72 SHBG (0.43) AKR1C3CYP3A4ESR1LMNASHBG
SCHEMBL1898745 0.71 CYP2C9 (0.37) CYP3A4LMNACYP1A2
SCHEMBL29446097 0.67 SHBG (0.70) AKR1C3CYP3A4ESR1LMNASHBG
SCHEMBL11096655 0.67 SHBG (0.70) AKR1C3CYP3A4ESR1LMNASHBG
SCHEMBL30887214 0.67 SHBG (0.70) AKR1C3CYP3A4ESR1LMNASHBG
SCHEMBL975788 0.67 SHBG (0.70) AKR1C3CYP3A4ESR1LMNASHBG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2039702-A2 Prodrugs erbeta-selective substances, method for their production and pharmaceutical compounds containing these compositions Bayer Schering Pharma Aktiengesellschaft (DE) 2009-03-25 EP disclosed